======= WDR26 ======= == Gene Information == * **Official Symbol**: WDR26 * **Official Name**: WD repeat domain 26 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=80232|80232]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H7D7|Q9H7D7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=WDR26&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20WDR26|Open PubMed]] * **OMIM**: [[https://omim.org/entry/617424|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. Two transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: G-beta-like protein involved in cell signal transduction (PubMed:15378603, PubMed:19446606, PubMed:22065575, PubMed:23625927, PubMed:27098453, PubMed:26895380). Acts as a negative regulator in MAPK signaling pathway (PubMed:15378603). Functions as a scaffolding protein to promote G beta:gamma- mediated PLCB2 plasma membrane translocation and subsequent activation in leukocytes (PubMed:22065575, PubMed:23625927). Acts as a negative regulator of the canonical Wnt signaling pathway through preventing ubiquitination of beta-catenin CTNNB1 by the beta-catenin destruction complex, thus negatively regulating CTNNB1 degradation (PubMed:27098453). Serves as a scaffold to coordinate PI3K/AKT pathway-driven cell growth and migration (PubMed:26895380). Protects cells from oxidative stress-induced apoptosis via the down-regulation of AP-1 transcriptional activity as well as by inhibiting cytochrome c release from mitochondria (PubMed:19446606). Protects also cells by promoting hypoxia- mediated autophagy and mitophagy (By similarity). {ECO:0000250|UniProtKB:F1LTR1, ECO:0000269|PubMed:15378603, ECO:0000269|PubMed:19446606, ECO:0000269|PubMed:23625927, ECO:0000269|PubMed:26895380, ECO:0000269|PubMed:27098453}. |WD40| |ubiquitin ligase complex| |mitochondrion| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp502|Milciclib 2μM R08 exp502]]|-4.58| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-3.63| |[[:results:exp382|Palbociclib 1μM R07 exp382]]|-3.35| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|-3.09| |[[:results:exp359|FK-506 30μM R07 exp359]]|-3.01| |[[:results:exp85|UM0129480 7μM R02 exp85]]|-2.99| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-2.93| |[[:results:exp67|BVD-523 15μM R02 exp67]]|-2.92| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|-2.84| |[[:results:exp59|UMK57 1μM R01 exp59]]|-2.74| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-2.63| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-2.48| |[[:results:exp90|WYE-354 6μM R02 exp90]]|-2.46| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|-2.4| |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|-2.4| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|-2.28| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|-2.24| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-2.2| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|-2.2| |[[:results:exp517|Quercetin 20μM R08 exp517]]|-2.14| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|-2.06| |[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|-1.96| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-1.95| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-1.9| |[[:results:exp492|iCRT14 30μM R08 exp492]]|-1.89| |[[:results:exp423|Zebularine 20μM R07 exp423]]|-1.88| |[[:results:exp61|YM155 0.0002μM R01 exp61]]|-1.87| |[[:results:exp346|CoCl2 18μM R07 exp346]]|-1.85| |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|-1.85| |[[:results:exp183|IU1-C 25μM R04 exp183]]|-1.8| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|-1.8| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-1.78| |[[:results:exp459|Bleomycin 5μM R08 exp459]]|-1.71| |[[:results:exp358|FK-506 5μM R07 exp358]]|-1.7| |[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|1.94| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|1.94| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|1.98| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|2.06| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|2.07| |[[:results:exp291|LLY-284 2.6μM R06 exp291]]|2.2| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|2.24| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|2.25| |[[:results:exp211|AICAR 240μM R05 exp211]]|2.28| |[[:results:exp264|Arsenate 40μM R06 exp264]]|2.36| |[[:results:exp485|GSK626616 14μM R08 exp485]]|2.64| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|3.08| |[[:results:exp116|AICAR 240μM R03 exp116]]|3.34| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|3.88| |[[:results:exp429|Rapamycin 0.001μM R08 exp429]]|3.94| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|4.43| ^Gene^Correlation^ |[[:human genes:y:ypel5|YPEL5]]|0.822| |[[:human genes:u:ube2h|UBE2H]]|0.765| |[[:human genes:g:gid8|GID8]]|0.751| |[[:human genes:m:maea|MAEA]]|0.697| |[[:human genes:m:memo1|MEMO1]]|0.526| |[[:human genes:r:rmnd5a|RMND5A]]|0.506| |[[:human genes:c:cnot8|CNOT8]]|0.473| |[[:human genes:o:otub1|OTUB1]]|0.466| |[[:human genes:g:gskip|GSKIP]]|0.449| |[[:human genes:a:anp32a|ANP32A]]|0.446| |[[:human genes:h:hgc6.3|HGC6.3]]|0.433| |[[:human genes:f:fkbp1a|FKBP1A]]|0.422| |[[:human genes:c:cnot2|CNOT2]]|0.416| |[[:human genes:p:pcgf1|PCGF1]]|0.415| |[[:human genes:k:kdm6a|KDM6A]]|0.413| |[[:human genes:g:gsk3b|GSK3B]]|0.41| Global Fraction of Cell Lines Where Essential: 30/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|2/28| |blood|0/28| |bone|4/26| |breast|3/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|1/16| |kidney|0/21| |liver|0/20| |lung|5/75| |lymphocyte|0/16| |ovary|3/26| |pancreas|1/24| |peripheral nervous system|0/16| |plasma cell|1/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|2/22| |urinary tract|2/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3796 * **Expression level (log2 read counts)**: 6.83 {{:chemogenomics:nalm6 dist.png?nolink |}}